PATENT CLAIM ANALYSIS

Application Number: 15872199
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-03
Patent Classification: ["514", "370000"]

Abstract:
The present invention relates to a compound of formula XXII and a compound of formula 17ya, which are defined as anywhere in the specification, to a composition comprising the same, and to a method of using thereof in the treatment of various forms of cancer.

Claim (Index 7):
The use according to  claim 4 , wherein the medicament is administered directly to a site where cancer cells are present.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 86.0
- Lexical Diversity: 1.53125
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14049950', '14692597', '13676650', '13216927', '12981233']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8443947100266749
- 35 USC 102 Novelty (BERT): 0.6167865888088472
- Combined Prediction Score: 0.8216338979048922
- Mean Citation Score: 529.1775359999998
- Max Citation Score: 609.86
- Similarity Product: 505.7506737494469

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test